Montauk Renewables occupies a distinctive niche in the clean-energy space, capturing methane from landfills and other non-fossil sources and converting it into RNG or renewable electricity. The third quarter of 2026 matters because it tests whether the company can translate growing production volumes into durable profitability. In recent periods, revenue has expanded even as net income has been squeezed by operating costs, facility-specific setbacks, and credit-related pressures. For investors, this report offers a clearer read on margin trajectory, RIN pricing dynamics, and whether management can stabilize its balance sheet ahead of year-end covenant deadlines. The results also carry weight for the broader renewable fuels sector, which remains sensitive to shifting regulatory and commodity conditions.
For the third quarter ended September 30, 2026, Montauk Renewables reported revenue of $50.19 million, an increase of 10.9% from $45.26 million in the prior-year period. Net income was $2.14 million, down from $5.21 million a year earlier, while basic and diluted EPS from continuing operations each totaled $0.01, compared with $0.04 in the same quarter last year.
The company generated an operating loss of $1.0 million, versus operating income of $4.4 million in the prior-year quarter. RNG production reached 1.5 million MMBtu, up 6.7% year over year, and RINs sold from operations climbed 12.2% to 13.9 million. For the first nine months of 2026, revenue totaled $150.64 million, up from $132.99 million a year earlier, with net income of $2.37 million versus a net loss of $0.75 million. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Sentiment around Montauk Renewables heading into and following this report has been shaped less by top-line growth than by the company's liquidity and leverage profile. Management disclosed that it executed a non-binding term sheet to amend its New Senior Credit Facility for additional debt and temporary covenant relief, and it cautioned that the company could be in default of those covenants as of December 31, 2026, if lender relief is not finalized. A more favorable signal came from the third-quarter Form 10-Q, which did not include the going-concern qualification that had previously been anticipated. Investors are likely to weigh the improving production metrics against the lingering uncertainty around the credit facility and the trajectory of operating margins.
Looking ahead, investors will be watching whether Montauk can convert its production gains into consistent operating profitability. Management reaffirmed full-year 2026 guidance of $175 million to $180 million in RNG revenue and $17 million to $19 million in REG revenue, giving the market a benchmark against which to measure execution through the fourth quarter.
The most pressing near-term variable is the credit facility negotiation. The company has signaled that it could breach certain covenants at year-end without lender relief, so the outcome of those discussions will be closely scrutinized for any change to borrowing capacity, interest costs, or financial flexibility.
Operationally, RIN pricing and environmental credit values remain a key swing factor for RNG margins, while performance at individual facilities will influence both output and repair-and-maintenance costs. Investors should also monitor any updates on facility-specific setbacks that have weighed on results, as well as broader demand signals in the renewable fuels and transportation markets. Together, these factors will help determine whether Montauk's revenue momentum translates into stronger bottom-line performance in the quarters ahead. From what I see, this is important because production growth alone may not be enough without margin stability.
In my own analysis, I often rely on Tickeron’s AI Screener to quickly filter renewable energy names by fundamentals, technical patterns, and AI signals. It helps surface comparable names and benchmark performance metrics without spending hours on manual screens, which keeps my workflow efficient when evaluating reports like this one.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
MNTK saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 10, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 54 instances where the indicator turned negative. In 50 of the 54 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MNTK as a result. In 75 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
MNTK moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MNTK crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MNTK's RSI Indicator exited the oversold zone, 27 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +15.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where MNTK advanced for three days, in 221 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
MNTK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.464) is normal, around the industry mean (2.284). P/E Ratio (54.400) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (1.709) is also within normal values, averaging (48.960).
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. MNTK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MNTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ChemicalsSpecialty